SMCI’s ongoing accounting debacle, filings delays, and Ernst & Young’s subsequent resignation have taken a significant toll on the stock’s performance.
Very well written. You bring up good points that have not been listed on other platforms. I would not even trade this stock.
Very well written. You bring up good points that have not been listed on other platforms. I would not even trade this stock.